COLLABORATIVE FOR EFFECTIVE PRESCRIPTION OPIOID POLICIES

Lobbying Spend

—

Filings

Firms Hired

Active Period

2016–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	1	1
2025	—	4	1
2024	—	4	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	6	2
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
FAEGRE BAKER DANIELS CONSULTING	—	17
FAEGRE DRINKER BIDDLE & REATH LLP	—	26

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	15
SENATE	15

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	17

COLLABORATIVE FOR EFFECTIVE PRESCRIPTION OPIOID POLICIES — Lobbying Disclosure | Poliscope